Who knew that a painkiller was poised to become a first-of-its-kind cancer cure? According to scientists from the Repurposing Drugs in Oncology (ReDO) project, a common painkiller known as Diclofenac, has cancer curing properties. ReDo is a cross-country collaboration between the Anticancer Fund in Belgium, and US-based GlobalCures. Research suggests that this unexpected discovery may be the advent of numerous drug therapies that can be used order to fight cancer.
“It’s still somewhat surprising that there is still so much we don’t understand about how many of the standard drugs we use every day, like Diclofenac. But the more we learn, the more we can see that these drugs are multi-targeted agents with interesting and useful effects on multiple pathways of interest in oncology.”
study author Dr. Pan Pantziarka, was quoted as saying in ScienceDaily.
Diclofenac is economical and occupies shelves in many a medical cabinet already. It is a non-steroidal anti-inflammatory drug (NSAID), and is used to treat conditions such as arthritis, migraine and post-operative pain. Although NSAIDs have exhibited cancer-preventing properties, it has now emerged that they may also prove successful in curing cancer, when paired with other treatments such as radiotherapy and chemotherapy.
It is definitely an exciting time in the sphere of medicine, with a blend of existing and new drugs that are coming together to form novel therapies!